Who Owns RGNX?

REGENXBIO Inc. — Institutional Ownership & 13F Holdings

$8.69

+0.07 (+0.81%)

Market Cap

$452.2M

Shares Outstanding

51,617,200

Institutional Holders

164

Total Inst. Value

$274.4M

% of Float Held

96.9%

QoQ Holder Change

+16

Institutional data as of Q1 2025

New Positions

36

Closed Positions

45

Increased

51

Decreased

54

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1BlackRock, Inc.$39.0M5,454,520
2Redmile Group, LLC$34.3M4,794,780
3JPMORGAN CHASE & CO$31.2M4,364,343
4VANGUARD GROUP INC$24.8M3,472,988
5MORGAN STANLEY$14.8M2,066,895
6BALYASNY ASSET MANAGEMENT L.P.$10.0M1,398,497
7DIMENSIONAL FUND ADVISORS LP$8.2M1,147,726
8GEODE CAPITAL MANAGEMENT, LLC$7.9M1,106,946
9STATE STREET CORP$7.6M1,066,093
10Integral Health Asset Management, LLC$6.6M925,000

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold RGNX?

As of Q1 2025, 164 institutional investors report holding RGNX (REGENXBIO Inc.) in their 13F filings.

What percentage of REGENXBIO Inc. is owned by institutions?

Institutional investors hold approximately 96.9% of REGENXBIO Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most RGNX?

The largest institutional holder of RGNX is BlackRock, Inc. with $39.0M in shares.

Are institutions buying or selling RGNX?

This quarter, 36 institutions opened new positions in RGNX and 45 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.